Annual CFF
$3.50 M
+$4.31 M+533.66%
December 31, 2023
Summary
- As of February 8, 2025, CMMB annual cash flow from financing activities is $3.50 million, with the most recent change of +$4.31 million (+533.66%) on December 31, 2023.
- During the last 3 years, CMMB annual CFF has fallen by -$1.25 million (-26.23%).
- CMMB annual CFF is now -94.26% below its all-time high of $61.07 million, reached on December 31, 2021.
Performance
CMMB Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
N/A
September 1, 2024
Summary
- CMMB quarterly cash flow from financing activities is not available.
Performance
CMMB Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFF
N/A
September 1, 2024
Summary
- CMMB TTM cash flow from financing activities is not available.
Performance
CMMB TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
CMMB Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +533.7% | - | - |
| 3 y3 years | -26.2% | - | - |
| 5 y5 years | -26.2% | - | - |
CMMB Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -94.3% | +533.7% | ||||
| 5 y | 5-year | -94.3% | +533.7% | ||||
| alltime | all time | -94.3% | +533.7% |
Chemomab Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $3.50 M(-533.7%) | - | - |
| Jun 2023 | - | $1.37 M(>+9900.0%) | $538.00 K(-166.6%) |
| Mar 2023 | - | $0.00(-100.0%) | -$808.00 K(0.0%) |
| Dec 2022 | -$808.00 K(-101.3%) | -$869.00 K(-2328.2%) | -$808.00 K(+3940.0%) |
| Sep 2022 | - | $39.00 K(+77.3%) | -$20.00 K(-84.7%) |
| Jun 2022 | - | $22.00 K(>+9900.0%) | -$131.00 K(-101.0%) |
| Mar 2022 | - | $0.00(-100.0%) | $13.28 M(-78.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $61.07 M(+1185.8%) | -$81.00 K(+12.5%) | $61.07 M(-1.0%) |
| Sep 2021 | - | -$72.00 K(-100.5%) | $61.72 M(-1.0%) |
| Jun 2021 | - | $13.43 M(-71.9%) | $62.35 M(+19.8%) |
| Mar 2021 | - | $47.80 M(+8390.1%) | $52.05 M(+995.8%) |
| Dec 2020 | $4.75 M | $563.00 K(+0.2%) | $4.75 M(+13.4%) |
| Sep 2020 | - | $562.00 K(-82.0%) | $4.19 M(+15.5%) |
| Jun 2020 | - | $3.13 M(+525.0%) | $3.63 M(+625.0%) |
| Mar 2020 | - | $500.00 K | $500.00 K |
FAQ
- What is Chemomab Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Chemomab Therapeutics?
- What is Chemomab Therapeutics annual CFF year-on-year change?
- What is the all time high quarterly CFF for Chemomab Therapeutics?
- What is the all time high TTM CFF for Chemomab Therapeutics?
What is Chemomab Therapeutics annual cash flow from financing activities?
The current annual CFF of CMMB is $3.50 M
What is the all time high annual CFF for Chemomab Therapeutics?
Chemomab Therapeutics all-time high annual cash flow from financing activities is $61.07 M
What is Chemomab Therapeutics annual CFF year-on-year change?
Over the past year, CMMB annual cash flow from financing activities has changed by +$4.31 M (+533.66%)
What is the all time high quarterly CFF for Chemomab Therapeutics?
Chemomab Therapeutics all-time high quarterly cash flow from financing activities is $47.80 M
What is the all time high TTM CFF for Chemomab Therapeutics?
Chemomab Therapeutics all-time high TTM cash flow from financing activities is $62.35 M